Drugs / TIV
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02307851 Comparator | Nov 2014 → Jun 2015 | influenza | Novavax | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TIV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02307851 ↗ |
| Modality | Vaccine | “commercially available trivalent influenza vaccine (TIV)” NCT02307851 ↗ |
| Route | Intramuscular | “intramuscular injection (0.5mL)” NCT02307851 ↗ |